B-all

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2022-12-08
Clinical Trial Update: Novel Anti-CD19 Universal CAR-T Cells for r/r CD19+ B-ALL [Phase 1, Phase 2]
A Phase 1/2 trial of novel anti-CD19 universal CAR-T cells for relapsed/refractory CD19+ B-cell acute lymphoblastic leukemia (B-ALL).